BioSpace News Archive

Lark Health, the leading chronic disease management and prevention platform, today announced Lark Prevention™, a new program that combines behavioral healthcare with traditional wellness to help members stay healthy and prevent chronic disease.

Designed and built in Milwaukee, the NIMBLE app is changing how doctors treat individuals who have cancer that has spread to the brain.

LifeOmic, the creator of the LIFE mobile apps and the Precision Health Cloud (PHC) platform in use at major medical and cancer centers, today announced a partnership with the Susan G. Komen Tissue Bank, a unique resource established by researchers at Indiana University Melvin and Bren Simon Cancer Center and Indiana University School of Medicine, to improve breast cancer research.

Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced its membership in the Partnership on AI (PAI) as its first ever healthcare member.

The Optical Society (OSA), co-locating with Optical Fiber Communication Conference and Exhibition (OFC), will hold the annual OIDA Executive Forum on 9 March 2020 at the Hilton San Diego Bayfront Hotel, U.S.A.

European and Japanese grants bring owned patents to 27 and additional Israel trademark award brings portfolio to new global audiences

Neurotrope, Inc. (the “Company”) (NASDAQ:NTRP) today announced that it has received commitments from institutional investors and pre-existing high net worth individuals to purchase an aggregate of $18 million of the Company’s securities in a registered direct offering.

The Discovery Labs and Deerfield Management Company have formed The Center for Breakthrough Medicines, a Contract Development and Manufacturing Organization (CDMO) and specialty investment company, to alleviate the critical lack of capacity that is preventing patients from accessing critically needed cell and gene therapies.

Polaryx Therapeutics, a biotech company developing patient-friendly small molecule therapeutics for lysosomal storage disorders announced today that the Company has received an Investigational New Drug Application (IND) approval from the U.S. Food and Drug Administration (FDA) for the treatment of LINCL patients with PLX-200.

Cambridge Healthtech Institute (CHI) today announced the return of Bioprocessing Summit Europe --the fastest growing bioprocessing meeting on the continent—with the addition of approximately 30 new sessions on Analytical and Formulation topics.